Emyria is involved in healthcare services, focusing on the development of innovative therapies and medical products. Self-described as an investment opportunity.

Emyria

Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.

Emyria Limited

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 5:31 AM	d11e5696
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 5:31 AM	5b187b47
crunchbase trigger	general	Nov 12, 2024 5:31 AM	e59e4cb5
crunchbase profile	general
li profile	general	Nov 12, 2024 5:31 AM	08f97998
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 5:31 AM	bed1a983
news basic	general	Nov 12, 2024 5:31 AM	6476096b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

EMD

COM:EMYRIA

Emyria

Last Close

0.04

22/11 05:10

Market Cap

20.86M

Beta: -

Volume Today

229.57K

Avg: -